User profiles for Robert Redd
 | Robert ReddDana-Farber Cancer Institute Verified email at ds.dfci.harvard.edu Cited by 7587 |
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
Diffuse large B cell lymphoma (DLBCL), the most common lymphoid malignancy in adults,
is a clinically and genetically heterogeneous disease that is further classified into …
is a clinically and genetically heterogeneous disease that is further classified into …
[HTML][HTML] PD-L1 and PD-L2 genetic alterations define classical Hodgkin lymphoma and predict outcome
Purpose Classical Hodgkin lymphomas (cHLs) include small numbers of malignant Reed-Sternberg
cells within an extensive but ineffective inflammatory/immune cell infiltrate. In cHL, …
cells within an extensive but ineffective inflammatory/immune cell infiltrate. In cHL, …
[HTML][HTML] Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation
Background Genetic mutations drive the pathogenesis of the myelodysplastic syndrome (MDS)
and are closely associated with clinical phenotype. Therefore, genetic mutations may …
and are closely associated with clinical phenotype. Therefore, genetic mutations may …
[HTML][HTML] Axicabtagene ciloleucel in the non-trial setting: outcomes and correlates of response, resistance, and toxicity
CA Jacobson, BD Hunter, R Redd… - Journal of Clinical …, 2020 - ncbi.nlm.nih.gov
PURPOSE Axicabtagene ciloleucel (axi-cel) was approved by the Food and Drug Administration
for relapsed aggressive B-cell non-Hodgkin lymphoma in part on the basis of durable …
for relapsed aggressive B-cell non-Hodgkin lymphoma in part on the basis of durable …
[HTML][HTML] Major histocompatibility complex class II and programmed death ligand 1 expression predict outcome after programmed death 1 blockade in classic Hodgkin …
Purpose Hodgkin Reed-Sternberg (HRS) cells evade antitumor immunity by multiple means,
including gains of 9p24. 1/CD274 (PD-L1)/PDCD1LG2 (PD-L2) and perturbed antigen …
including gains of 9p24. 1/CD274 (PD-L1)/PDCD1LG2 (PD-L2) and perturbed antigen …
Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma
Personal neoantigen vaccines have been envisioned as an effective approach to induce,
amplify and diversify antitumor T cell responses. To define the long-term effects of such a …
amplify and diversify antitumor T cell responses. To define the long-term effects of such a …
Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma
Signaling between programmed cell death protein 1 (PD-1) and the PD-1 ligands (PD-L1,
PD-L2) is essential for malignant Hodgkin Reed-Sternberg (HRS) cells to evade antitumor …
PD-L2) is essential for malignant Hodgkin Reed-Sternberg (HRS) cells to evade antitumor …
[HTML][HTML] Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma
PURPOSE Patients with relapsed or refractory primary mediastinal large B-cell lymphoma (rrPMBCL)
have a poor prognosis, and their treatment represents an urgent and unmet need. …
have a poor prognosis, and their treatment represents an urgent and unmet need. …
[HTML][HTML] Nivolumab for newly diagnosed advanced-stage classic Hodgkin lymphoma: safety and efficacy in the phase II CheckMate 205 study
PURPOSE Nivolumab, an anti–programmed death-1 monoclonal antibody, has demonstrated
frequent and durable responses in relapsed/refractory classic Hodgkin lymphoma (cHL). …
frequent and durable responses in relapsed/refractory classic Hodgkin lymphoma (cHL). …
Atorvastatin for anthracycline-associated cardiac dysfunction: the STOP-CA randomized clinical trial
…, S Nasta, RY Kwong, M Jerosch-Herold, RA Redd… - JAMA, 2023 - jamanetwork.com
Importance Anthracyclines treat a broad range of cancers. Basic and retrospective clinical
data have suggested that use of atorvastatin may be associated with a reduction in cardiac …
data have suggested that use of atorvastatin may be associated with a reduction in cardiac …
